Ledger.Open graph →
SEC Form D · filed July 21, 2020

Unum Therapeutics Inc

Offering
$44.8M
Sold
$44.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Karen L. Ferrante · Cambridge, MADirectorCharles Wilson · Cambridge, MAExec · DirectorJessica L. Sachs · Cambridge, MAExecJohn L. Green · Cambridge, MAExecChris L. Cain · Cambridge, MADirectorArlene L. Morris · Cambridge, MADirectorPeter L. Harwin · Cambridge, MADirectorMatthew L. Ros · Cambridge, MADirectorTracey E. Griffin · Boca Raton, FLDirectorEric L. Press · Boca Raton, FLDirectorDavid Rossini · Denver, COExec · DirectorSamuel Landenwitsch · Denver, CODirectorJames D. Devries · Boca Raton, FLExecMatthew H. Nord · Boca Raton, FLDirectorReed B. Rayman · Boca Raton, FLDirectorMarc S. Jones · Boca Raton, FLExecUpper90 Partners Equity SPV GP III LLC · New York, NYDirectorRafael Colorado · Dallas, TXExecKimberly L. Grimm · Menomonee Falls, WIDirectorGlenn Harrison · Nashville, TNDirectorPaul Del Vecchio · Portland, ORDirectorJosh Bean · Portland, ORExec · DirectorShobi Dahl · Portland, ORDirectorPancham Gupta · Jericho, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗